Clinical Trial Update: Treatment for Advanced Non-small Cell Lung Cancer With Actionable Genomic Alterations After Targeted Treatment and Chemotherapy (An Expanded Lung-MAP Treatment Trial) [Phase 2]

View source ↗

Summary

Phase 2 expanded Lung-MAP trial evaluating treatment for advanced non-small cell lung cancer with actionable genomic alterations after prior targeted therapy an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 | Phase 2 | Status: NOT_YET_RECRUITING